Skip to main content
. 2021 Sep 17;22(18):10048. doi: 10.3390/ijms221810048
2-AGE noladin ether
Abn-CBD abnormal-cannabidiol
APCA arachidonylcyclopropylamide
ARA-S arachidonoyl-L-serine
CB1,2-R cannabinoid receptor types 1 and 2
CBD cannabidiol
CBRs cannabinoid receptors
DAGL-α,β diacylglycerol lipases α,β
DHEA docosahexaenoyl ethanolamid
DEA docosatetraenoyl ethanolamide
ECS endocannabinoid system
EDH endothelium-dependent hyperpolarization
EPEA eicosapentaenoyl ethanolamide
ERAs endothelin receptor antagonists
HEA homo-γ-linolenyl ethanolamide
hPAs human pulmonary arteries
LEA inolenoyl ethanolamide
2-LG linoleoylglycerol
LPI L alpha-Lysophosphatidylinositol
MCT monocrotaline
MethAEA methanandamide
NAGly N arachidonoyl glycine
ODA oleamide
OEA oleoyl ethanolamide
PAH pulmonary arterial hypertension
POEA palmitoleoyl ethanolamide
PAP pulmonary arterial pressure
PASMCs pulmonary artery smooth muscle cells
PEA ethanolamide
PH pulmonary hypertension
PPAR-γ peroxisome proliferator-activated receptor-γ
PVR pulmonary vascular resistance
rPA rat pulmonary artery
RVSP right ventricular systolic pressure
SEA stearoyl ethanolamide
U46619 analogue of thromboxane A2
VIR virodhamine